WebFeb 28, 2024 · Developer Incanthera Class Antineoplastics; Colchicum alkaloids; Drug conjugates; Peptides Mechanism of Action Vascular disrupting agents Orphan Drug Status No New Molecular Entity Yes Highest Development Phases No development reported Breast cancer; Colorectal cancer; Lung cancer; Prostate cancer Most Recent Events WebIncanthera PLC is a UK-based, dermatology and oncology therapeutics company focusing on drug discovery and development of targeted medicines for the treatment of cancer. Deep dive We explore the...
Incanthera Ltd. - Product Pipeline Review - 2015 - The Pharma Letter
WebMar 1, 2024 · Assignee: Incanthera Ltd Inventors: Robert Andrew Falconer, Jason Gill, Jennifer Xavier, Paul Loadman, Michael Bibby, Laurence Patterson Methods Of Treating Cancer Using Compounds Containing A Vascular Disrupting Agent. Publication number: 20240266307 ... WebNov 8, 2015 · This report provides comprehensive information on the current therapeutic developmental pipeline of Incanthera Ltd.’s, complete with comparative analysis at … recycling in mexico
Incanthera - Overview, News & Competitors ZoomInfo.com
WebMar 10, 2014 · North West oncology company Incanthera Ltd has acquired University of Salford drug discovery spin-out Onco-NX Ltd. The deal represents the first successful sale of a spin-out company from the University and will see both companies combine their expertise in targeted anticancer drugs, to develop a ground-breaking, therapeutics pipeline. WebAcoustic Sensing Technology (UK) Ltd was created in 2013, as a new Company, with investment from the North West Fund managed by 350 Investment Partners to provide new technology for the water industry and for other industries, both in the UK and worldwide. ... Incanthera. Incanthera is a revolutionary oncology company with a unique pipeline of ... WebIncanthera Ltd is a Biotechnology, Pharmaceuticals, and Drug Discovery company located in Manchester, Manchester with $1.00 Million in revenue and 6 employees. Find top … klean wine where to buy